Professional

UK transition licensing frequently asked questions

We license more than 800 establishments that store and use human tissue for purposes such as patient treatment, organ transplantation, post mortem examination, research, teaching, and public exhibitions. The information below covers the frequently asked question in relation to the UK transition. 

If you are an establishment based in GB that imports or exports human tissues or cells between GB and a country in the European Economic Area (EEA), you may need a licence that covers these activities. 

UK Transition guidance

The United Kingdom (UK) has left the European Economic Area (EEA) single market and customs union. This has resulted in regulatory changes in the UK, including some that apply to the movement of human tissues and cells between Great Britain (GB), Northern Ireland (NI), and the EEA.

Establishments importing or exporting human tissues and cells intended for human application (patient treatment) may require a HTA licence covering these activities.

How to make changes to your licence

It is a legal requirement to inform the HTA of any changes to your licence or contact details. This ensures we can reach the Designated Individual (DI) and Licence Holder (LH) or Corporate Licence Holder contact (CLHc). Please email updates and variation requests to licensing@hta.gov.uk.

An application to vary a licence can be made by either the DI or the LH / CLHc, with the exception of a change of DI which needs to be submitted by the LH / CLHc.

Disposal of anatomical specimens

Disposal of relevant material is one of the statutory activities within the remit of the Human Tissue Authority (HTA). However, the Human Tissue Act 2004 (HT Act) does not mandate any particular method of disposal according to the type or size of the relevant material. Further, it does not specify how to dispose of imported relevant material.